Philippe P. Monnier
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Elezanumab for the treatment of spinal cord injury: assessing the clinical development journey to date.
Journal: Expert opinion on investigational drugs
Published: July 07, 2026
Clinical stage anti-RGMa monoclonal antibody elezanumab promotes bladder recovery and neuroplasticity after traumatic spinal cord injury.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 15, 2026
PLX5622 did not alter anxiety-like behaviour and showed limited microglial depletion efficacy in a spinal cord injury model in female rats.
Journal: Scientific reports
Published: December 15, 2025
Deneddylation of ribosomal proteins promotes synergy between MLN4924 and chemotherapy to elicit complete therapeutic responses.
Journal: Cell reports
Published: November 13, 2025
Disruption of major Ptchd1 isoforms causes autistic traits in social behavior and communication.
Journal: Molecular psychiatry
Published: May 31, 2025
Identification of a T2-hyperintense Perivascular Space in Brain Arteriovenous Malformations.
Journal: In vivo (Athens, Greece)
Published: September 15, 2024
Functional characterization of optic photoreception in Lymnaea stagnalis.
Journal: PloS one
Published: May 07, 2024
Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets.
Journal: Frontiers in neurology
Published: May 03, 2024
Inhibition of proprotein convertase SKI-1 prevents blood vessel alteration after stroke.
Journal: Nature cardiovascular research
Published: April 24, 2024
Landscapes of gut microbiome and blood metabolomic signatures in relapsing remitting multiple sclerosis.
Journal: Science China. Life sciences
Published: February 07, 2024
Last Updated: 09/26/2026